
Spotlight: rare diseases and innovative therapies is a virtual webinar series exploring agile strategies for accelerating collaboration and patient focus in a post-COVID Europe, taking place over on The Evidence Base.
Advisory board

Charles Makin
Charles Makin is the Global Head of Real-World Evidence Strategy at Biogen (MA, USA). In Makin’s current position, he oversees real-world evidence projects across all therapeutic areas for ...

Dalia Dawoud
Dalia Dawoud is the Scientific Adviser on the Science, Policy and Research Programme at The National Institute for Health and Care Excellence (NICE; London, UK). Dawoud has a Doctor of Philosophy ...

Karen Facey
Karen Facey is a Senior Research Fellow at the Usher Institute of Population Health Sciences and Informatics at the University of Edinburgh (Edinburgh, UK). In her current role, Facey acts as the ...